eagle ""while Prima Biomeds plan is structured on the basis of proving Cvac to the point of commercialisation that would not necessarily mean that a partnership, merger or takeover would not occur.""
If i recall correctly, their statement was to 'maximise the upside' to Prima. This could include partnerships, licensing etc. but I think it was mentioned they'd like to take it as far as they can on their own or at least with majority control.
The more results Prima can get under their belt before needing outside help, the better the deal they could negotiate.
potential market size of muc1 cancers for cvac, page-19
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |